/CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announces today that its Maltese joint venture, ZenPharm Limited ("ZenPharm"), has.
Zenabis Global Inc. s (TSX:ZENA) Maltese joint venture,
ZenPharm Limited, was given the green light to produce cannabis for medicinal and research purposes in the Mediterranean island country.
The license issued by the Malta Medicines Authority comes on the heels of receipt of the European Union Good Manufacturing Practices certification, which was issued by the same regulatory body in February.
The Canadian cannabis producer is now set to import in bulk from its facility in Atholville.
ZenPharm already inked a supply deal with a customer in Germany to provide a minimum volume of 500 kg per year.
In addition, ZenPharm agreed to accept shipments of up to 300kg from the Atholville-based facility through year-end.
BUZZ-Zenabis Global rises as JV gets approval for cannabis distribution Reuters 5/14/2021 Shares of pot producer up as much as 4.35% at C$0.12 Malta Medicines Authority grants ZENA s JV, ZenPharma, license to produce cannabis for medicinal and research purposes The license allows for commercial bulk imports into Malta from co s facility in Atholville and exports of finished medicinal cannabis products to European Union countries and UK Both HEXO Corp and co s combined product portfolio is expected to gain access to the European market, of which Germany is most prominent target Pot producer Materia won European Union certification for its Malta facility to produce and export cannabis flower across the continent on Thursday
Materia Announces Receipt of EU-GMP Certification in Malta
Materia Malta or the
EU GMP ) certification from the Malta Medicines Authority.
EU GMP is the global gold standard for pharmaceutical production and a requirement for medical cannabis in most European jurisdictions. This certification will enable Materia to begin processing and exporting medical cannabis flower from Malta into end markets across Europe, following the final post-certification steps in accordance with the licensure process. The Company also intends to apply for a licence amendment to process cannabis extracts imminently, leveraging the comprehensive preparatory work already completed. Becoming EU GMP certified in Malta represents our most significant milestone since we embarked on this project over two years ago, said Deepak Anand, CEO of Materia. We are excited to turn the engine on and showcase the full potential of a Malta-based cannabis processor to the industry, especially global partners seeking